Cooper Companies (NASDAQ:COO) Insider Holly Sheffield Acquires 1,230 Shares of Stock

The Cooper Companies, Inc. (NASDAQ:COO) insider Holly Sheffield purchased 1,230 shares of the business’s stock in a transaction that occurred on Tuesday, December 16th. The stock was purchased at an average price of $80.75 per share, for a total transaction of $99,322.50. Following the completion of the transaction, the insider directly owned 39,052 shares in the company, valued at $3,153,449. This trade represents a 3.25% increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which is available at this link.

Cooper Companies Stock Down 0.6%

Shares of NASDAQ COO opened at $81.04 on Wednesday. The Cooper Companies, Inc. has a 52-week low of $61.78 and a 52-week high of $100.24. The company has a debt-to-equity ratio of 0.30, a quick ratio of 1.13 and a current ratio of 1.89. The stock has a market cap of $15.88 billion, a P/E ratio of 43.11, a P/E/G ratio of 2.33 and a beta of 1.05. The firm has a 50 day moving average price of $73.91 and a 200 day moving average price of $71.74.

Cooper Companies (NASDAQ:COO) last posted its earnings results on Thursday, December 4th. The medical device company reported $1.15 earnings per share for the quarter, topping the consensus estimate of $1.11 by $0.04. Cooper Companies had a net margin of 9.16% and a return on equity of 10.02%. The company had revenue of $1.07 billion for the quarter, compared to analyst estimates of $1.06 billion. During the same period last year, the business posted $1.04 earnings per share. The business’s revenue for the quarter was up 4.6% compared to the same quarter last year. Cooper Companies has set its FY 2026 guidance at 4.450-4.600 EPS and its Q1 2026 guidance at 1.020-1.040 EPS. Analysts expect that The Cooper Companies, Inc. will post 3.98 EPS for the current year.

Cooper Companies declared that its board has authorized a stock buyback program on Wednesday, September 17th that allows the company to buyback $2.00 billion in outstanding shares. This buyback authorization allows the medical device company to purchase up to 15.4% of its stock through open market purchases. Stock buyback programs are typically an indication that the company’s management believes its stock is undervalued.

Hedge Funds Weigh In On Cooper Companies

A number of large investors have recently bought and sold shares of the company. Horizon Investments LLC raised its holdings in Cooper Companies by 5.0% in the first quarter. Horizon Investments LLC now owns 2,859 shares of the medical device company’s stock worth $241,000 after purchasing an additional 136 shares in the last quarter. Wealth Alliance LLC grew its position in shares of Cooper Companies by 4.2% in the 2nd quarter. Wealth Alliance LLC now owns 4,230 shares of the medical device company’s stock worth $301,000 after buying an additional 171 shares during the period. Mesirow Financial Investment Management Inc. increased its stake in shares of Cooper Companies by 1.3% in the 3rd quarter. Mesirow Financial Investment Management Inc. now owns 14,017 shares of the medical device company’s stock worth $961,000 after acquiring an additional 175 shares in the last quarter. Pacer Advisors Inc. lifted its position in Cooper Companies by 0.8% during the 3rd quarter. Pacer Advisors Inc. now owns 23,079 shares of the medical device company’s stock valued at $1,582,000 after acquiring an additional 182 shares during the period. Finally, Citizens Financial Group Inc. RI lifted its position in Cooper Companies by 2.7% during the 3rd quarter. Citizens Financial Group Inc. RI now owns 7,181 shares of the medical device company’s stock valued at $492,000 after acquiring an additional 192 shares during the period. Institutional investors and hedge funds own 24.39% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities research analysts have issued reports on COO shares. Robert W. Baird increased their price target on Cooper Companies from $85.00 to $98.00 and gave the stock an “outperform” rating in a report on Friday, December 5th. Needham & Company LLC reiterated a “buy” rating and issued a $100.00 price objective (up from $94.00) on shares of Cooper Companies in a research report on Friday, December 5th. The Goldman Sachs Group restated a “sell” rating and set a $71.00 target price (up from $64.00) on shares of Cooper Companies in a report on Monday, December 8th. Citigroup reiterated a “neutral” rating and issued a $88.00 price target (up previously from $72.00) on shares of Cooper Companies in a report on Monday, December 8th. Finally, JPMorgan Chase & Co. increased their price objective on shares of Cooper Companies from $66.00 to $78.00 and gave the stock a “neutral” rating in a research report on Friday, December 5th. One investment analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, five have issued a Hold rating and two have assigned a Sell rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $90.15.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.